We caught up with Ercan Altınöz, Associate Professor of Psychiatry at Eskişehir Osmangazi University School of Medicine in Eskişehir, Turkey, who told us how combining CANTAB® tasks with machine learning may help to improve diagnosis of bipolar disorder.
We caught up with Dr Ferenc Magyari from the University of Debrecen, who told us how CANTABTM has helped them to understand the long-term cognitive impact of Hodgkin’s Lymphoma.
Amy Tiberio was one of the winners of the 2022 CANTABTM Research Grant. Here she explains more about her project and what winning this grant means for her.
We caught up with Shefali Thanawala from Nutriventia Ltd who told us how CANTABTM helped them to investigate the effects of Ashwagandha root extract on memory and focus in healthy, stressed adults.
To mark World Alzheimer's Day, we hear from Christoffer Hatlestad-Hall and his team at Oslo University Hospital, who explain how CANTABTM is an instrumental part of their study using AI and machine learning to identify the earliest signs of Alzheimer's and dementia in people with mild cognitive impairment.
We caught up with Victoria Leong from Nanyang Technological University and University of Cambridge who told us how the COVID-19 pandemic has required a shift to web-based testing and how CANTABTM tasks can be used as part of a rigorous online cognitive testing methodology.
We caught up with Xinyue (Joyce) Jiang from the Centre for Addiction and Mental Health in Toronto to hear more about how her team used CANTABTM tasks to understand the effect of antipsychotic medication on cognition in young people affected by bipolar disorder.
We caught up with Dr Rebecca Power from South East Technological University about how CANTABTM has helped her team to investigate the impact of specific nutrients on cognitive performance.
We caught up with Martin Gillies from the University of Oxford, who told us how CANTABTM tasks help his team to probe the cognitive electrophysiology of the deep brain, particularly focusing on the cognitive role of the dorsal Anterior Cingulate Cortex (dACC) in decision-making.
We recently caught up with Atiqul Haq Mazumder, a doctoral researcher at the University of Oulu, Finland. Here, he tells us about how he used CANTAB to understand more about whether hazardous drinking could affect cognition in people with schizophrenia, schizoaffective disorder and bipolar disorder.
We caught up with Professor Eirini Flouri from University College London, to discuss the role CANTAB played in her research into gendered friendships and decision-making in adolescence.
Using CANTAB to identify undiagnosed dementia cases using a web-based pre-screening tool in the MOPE
We recently caught up with Dr. Mercè Boada, the project coordinator of MOPEAD, and Medical Director of Ace Alzheimer Center Barcelona to discuss her recent publication supporting the use of CANTAB for the early detection of undiagnosed people with cognitive impairment.
Florin Tibu from the Department of Health and Human Development at the Stefan cel Mare University of Suceava recently gave us an insight into how CANTAB has impacted his research into targeting adolescent neurocognitive processes in depression to promote intervention response.
We caught up with Dr. Guy Haller from Geneva University Hospital, to discuss the role CANTAB played in the international ENIGMA II substudy on postoperative cognitive disorders (ISEP)
Using CANTAB to understand the role of cognitive control and rumination in predicting depression amo
We recently caught up with Sanja Jandric, from the University of Osijek to discuss her research into the role of cognitive control and rumination in predicting depression among adolescents with internalising disorders.
We recently caught up with Insa Feinkohl from the BioCog Consortium, to discuss the research they’ve been conducting, focusing on investigating the role of cognitive reserve in cognitive ageing.
Using CANTAB to compare the effects of augmented reality N-back training and traditional two-dimensi
We recently caught up with Dr Bo Zhang from East China Normal University to discuss her research: A Comparison of the Effects of Augmented Reality N-Back Training and Traditional Two-Dimensional N-Back Training on Working Memory
We caught up with Julius Rave to talk about the impact that the primary 2021 CANTAB Research Grant prize will have on his research: Exploring structural and functional changes in memory-associated networks in patients expressing cognitive deficits after a COVID-19 infection.
Pim Heckman speaks to us about the impact that receiving one of the three 2021 CANTAB Research Grant prizes will have on his research into clearing COVID-19 cognitive brain fog
Jamileth More recently spoke to us about the impact that receiving one of the three 2021 CANTAB Research Grant prizes will have on her research into monitoring protocol of COVID-19 patients survivors of mechanical ventilation.
CANTAB used to assist with identifying patients with mild cognitive impairment and subjective cognit
Dr. Andrea McGrattan, a Research Dietitian and Lecturer in Nutrition and Dietetics, spoke to us about her PhD research at Queen’s University Belfast, using CANTAB cognitive testing within a Mediterranean Diet feasibility study, “THINK-MED”, among people with cognitive impairment.
Find out more about how María Campos Magdaleno, PhD of Universidade de Santiago de Compostela is using CANTAB to investigate cognitive changes in typical and pathological ageing.
CENTRE-TBI recently concluded their 10 year study into the relationship between cognition and function in daily life after traumatic brain injury. We caught up with Prof Lindsay Wilson to hear the key findings from this worldwide study.
Using CANTAB to investigate specific contributions from the volume of hippocampal subregions to visu
We recently caught up with Tamara Shavitt, a psychology student who conducted research at the Faculty of Medicine, University of São Paulo to discuss how CANTAB impacted her research: investigate specific contributions from the volume of hippocampal subregions to visuospatial memory tasks.
New study finds CANTAB is sensitive to very early cognitive changes in premanifest Huntington’s dise
Dr. Christelle Langley, postdoctoral Research Associate at the University of Cambridge School of Clinical Medicine shared the role that CANTAB played in her latest publication: Fronto-striatal circuits for cognitive flexibility in far from onset Huntington’s Disease: Evidence from the Young Adult Study
We recently spoke with Dr Lisa Evju Hauger to discuss the impact CANTAB had on her research into exploring executive function in relation to long-term anabolic androgenic steroids (AAS) use and dependence.
Using CANTAB to examine the potential synergistic effects of a combination of omega-3 fatty acids, c
Dr Rebecca Power, Postdoctoral Researcher at the Nutrition Research Centre Ireland, shared the role that CANTAB played in her latest publication: Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
Ciara Molloy recently spoke to us about the impact that receiving one of the three 2020 CANTAB Research Grant prizes will have on her research: ‘The impact of rare copy number variants on cognition: Defining cognitive phenotypes in individuals with CNVs associated with neurodevelopmental and neuropsychiatric disorders.’
2020 CANTAB Research Grant supports research into combined dexmedetomidine / ketamine nasal spray fo
The winner of one of the three 2020 CANTAB Research Grant prizes, Dr Amie Hayley, Swinburne University of Technology explains the impact CANTAB will have on her research: Combined dexmedetomidine/ketamine nasal spray for analgesia: a pilot feasibility and efficacy trial.
Dr Simone De Luca recently received the 2020 CANTAB Research Grant primary award for her project: “New ways to assess vascular cognitive impairment and dementia (VCID) in chronic lung disease”. We spoke to her about the impact winning would have on her research.